Race options thread, page-118

Yes. There are a considerable number of preclinical programs we would undertake that will create serious value if we have the cash to do them. Early conversion would also allow us to commit to the AML clinical program earlier, speeding up getting that underway too. Even having part of the cash early would allow us to do some of the budgeted project early and build value sooner.

Ultimately, while we would love everyone to convert early, we know that for many of our shareholders they are not in the financial position to do so, especially at this time of year. This is why we have chosen the bonus option path with a 6 month timeframe rather than say like MSB who went down the path of a 1 for 4 rights issue that needs to be paid just before Christmas.